Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1996-07-03
2000-07-18
Stucker, Jeffrey
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242041, 4242051, 4352351, C12N 700
Patent
active
060903937
ABSTRACT:
Disclosed and claimed are recombinant adenoviruses, methods of making them, uses for them (including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing DNA and methods of using the compositions and vector), expression products from them, and uses for the expression products. More particularly, disclosed and claimed are recombinant canine adenoviruses (CAV) and methods of making them, uses for them, expression products from them, and uses for the expression products, including recombinant CAV2 viruses. Additionally, disclosed and claimed are truncated promoters, expression cassettes containing the promoters, and recombinant viruses and plasmids containing the promoters or expression cassettes.
REFERENCES:
patent: 4963481 (1990-10-01), deVilliers
patent: 5585237 (1996-12-01), Oppermann et al.
patent: 5585362 (1996-12-01), Wilson et al.
patent: 5616326 (1997-04-01), Spibey
Horwitz, MS. Fields Virology. Third Ed. vol. 2, chap 68, p. 2165-2171, 1996 .
Frommer William S.
Kowalski Thomas J.
Merial
Stucker Jeffrey
LandOfFree
Recombinant canine adenoviruses, method for making and uses ther does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant canine adenoviruses, method for making and uses ther, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant canine adenoviruses, method for making and uses ther will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2033891